News

doctor notes

Agentic large-language models can draft hospital discharge summaries that are safe, useful and demonstrably effective at helping to curb physician burnout, according to research conducted at Stanford University.

Subhasis Chatterjee, MD. FACS, FACC, FCCP, Associate Professor of Surgery, Director Thoracic Surgical ICU and ECMO Program, Texas Heart Institute at CHI Baylor St. Lukes, explains the new 2026 expert consensus on heparin induced thrombocytopenia (HIT) released at the American Association for Thoracic Surgery (AATS) 2026 annual meeting. #AATS #AATS2026 #AATS26

Heparin-induced thrombocytopenia after heart surgery is a major concern, but prior guidelines were developed without much feedback from actual cardiac surgeons.

doctor wrong patient wrong-site surgery medical error malpractice mistake

Medline already had to recall millions of syringes due to a significant safety risk. Now, multiple procedure kits that include the devices are also being recalled. The issue has been associated with four serious injuries.

As popular as TAVR is today, SAVR continues to play a significant role in the management of patients with valvular disease. 

Nicole B. Saphier, MD

“Dr. Saphier would be a catastrophic mistake on messaging and communicating with MAHA at a time where the coalition is very fragile,” one opponent says. 

Siemens Healthineers

The Erlangen, Germany-based device manufacturer announced its quarterly earnings results on May 7, which included a 6.5% year-over-year decline in revenue for its diagnostics segment. 

Thumbnail

First approved by the FDA in 2021, providers have rapidly adopted this clinical innovation, which offers greater accuracy in detecting prostate cancer. 

GLP-1 receptor agonists (GLP-1-RAs) have become the wonder drug not only of weight loss, but also for improving cardiovascular health in a growing number of positive cardiovascular trials. The latest study of more than 13,000 patients presented at Heart Rhythm 2026 this week showed the GLP-1 reduce atrial fibrillation (AFib) and survival, even after accounting for the drug’s impact on weight loss.

The agency said the new program, made possible by Medicare Part D, begins on July 1 and will extend until the end of 2027. For $50 a month, Medicare beneficiaries will be able to access popular weight loss drugs, in hopes they will improve overall health.

SS Innovations International SSi Mantra 3 robotic surgery system

The company's SSi Mantra 3 robotic surgery system has already gained regulatory approvals in several countries. FDA approval is anticipated by late 2025 or early 2026.

This problem doesn't just affect imaging staff but all healthcare workers, one organization cautions.

Drugs money scam

Janmarie Lanzo is charged with conspiracy to violate the Food, Drug, and Cosmetic Act and defraud the FDA, according to the indictment. 

the words "FDA recall" on a board

Vendor Centerline Biomedical recently initiated the action, removing certain IOPS (Intra-Operative Positioning System) Guidewires, used in vascular procedures, from the market. 

Around the web

Agentic large-language models can draft hospital discharge summaries that are safe, useful and demonstrably effective at helping to curb physician burnout, according to research conducted at Stanford University.

Heparin-induced thrombocytopenia after heart surgery is a major concern, but prior guidelines were developed without much feedback from actual cardiac surgeons.

Medline already had to recall millions of syringes due to a significant safety risk. Now, multiple procedure kits that include the devices are also being recalled. The issue has been associated with four serious injuries.